Free Trial
Christopher Carey

Christopher Carey Analyst Performance

Senior Equity Analyst - Head of Consumer Staples Research at Wells Fargo & Company

Christopher Carey is a stock analyst at Wells Fargo & Company across a range of sectors, covering 13 publicly traded companies. Over the past year, Christopher Carey has issued 7 stock ratings, including and hold recommendations. While full access to Christopher Carey's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Christopher Carey's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
46 Last 8 Years
Buy Recommendations
41.30% 19 Buy Ratings
Companies Covered
13 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy41.3%19 ratings
Hold28.3%12 ratings
Sell30.4%14 ratings

Out of 46 total stock ratings issued by Christopher Carey at Wells Fargo & Company, the majority (41.3%) have been Buy recommendations, followed by 30.4% Sell and 28.3% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
53.8% of companies on NYSE
7 companies
NASDAQ
38.5% of companies on NASDAQ
5 companies
TSE
7.7% of companies on TSE
1 company

Christopher Carey, an analyst at Wells Fargo & Company, currently covers 13 companies listed on NYSE, NASDAQ and TSE, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Consumer Staples
7 companies
53.8%
Medical
5 companies
38.5%
Retail/Wholesale
1 company
7.7%

Christopher Carey of Wells Fargo & Company specializes in stock coverage within the Consumer Staples sector, with additional focus on Medical and Retail/Wholesale companies.

Coverage Industries

IndustryPercentage
CONS PD - MISC STPL
3 companies
23.1%
MED PRODUCTS
3 companies
23.1%
COSMETICS&TLTRS
2 companies
15.4%
BEVERAGES - ALCOH
1 company
7.7%
AGRI OPERATIONS
1 company
7.7%
DRUG MANUFACTURERS - SPECIALTY & GENERIC
1 company
7.7%
FOOD ITEMS - WHLE
1 company
7.7%
MED - DRUGS
1 company
7.7%

Christopher Carey's Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
5/4/2026Boost Price Target$80.87$85.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
4/8/2026Lower Price Target$71.44$75.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
3/24/2026Lower Price Target$78.92$90.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
2/6/2026Lower Price Target$104.02$105.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
1/5/2026Boost Price Target$108.81$111.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
10/31/2025Boost Price Target$96.82$95.00Equal Weight
The Estee Lauder Companies Inc. stock logo
EL
Estee Lauder Companies
7/9/2025Boost Price Target$85.63$90.00Equal Weight